Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Double-Blind Study of Ibuprofen 5% Topical Gel for Ankle Sprain Pain
2015-001874-16Phase 3
- Sponsor
- Pfizer
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Ankle sprain comparing Ibuprofen 5% topical gel with Topical placebo gel (2 arms). Primary endpoint: Sum of pain intensity difference on weight bearing over 24 hours after first dose.
02
Drugs
ibuprofen
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on 2015-001874-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001874-16.